Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxelidine for postoperative analgesia after laparoscopic total hysterectomy
ChiCTR2500099358Phase 4Not yet recruiting
- Sponsor
- Hefei Second People's Hospital
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in postoperative pain (2 arms), sponsored by Hefei Second People's Hospital. Primary endpoints: Postoperative pain severity, PCA press times and 1 more. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500099358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500099358.